Insulin Sensitivity and Substrate Metabolism in Patients With Cushing's Syndrome
NCT00682084 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1
Last updated 2017-12-22
Summary
The purpose of this study is to investigate the effect og chronic elevated levels of cortisol on metabolism and insulin sensitivity.
Conditions
Interventions
- PROCEDURE
-
Surgery
Surgical removal of either a pituitary or ectopic ACTH producing tumor or an adrenal tumor
Sponsors & Collaborators
-
Aarhus University Hospital
collaborator OTHER -
University of Aarhus
lead OTHER
Principal Investigators
-
Jens Otto L. Jørgensen, Professor MD · Aarhus University Hospital, Department of Endocrinology
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-04-30
- Primary Completion
- 2016-11-30
- Completion
- 2016-11-30
Countries
- Denmark
Study Locations
More Related Trials
-
Metabolic Studies- Interactions Between GH and Insulin in GHDA
NCT00568568 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate CORT125134 in Participants With Cushing's Syndrome
NCT02804750 ·Status: COMPLETED ·Phase: PHASE2
-
Long Term Post Operative Follow-Up of Cushing Syndrome
NCT00029952 ·Status: COMPLETED
-
Hair Cortisol and Cushing's Disease
NCT04201444 ·Status: COMPLETED ·Phase: NA
-
Metabolic Effects of Acute Cortisol Withdrawal in Adrenal Failure
NCT00442390 ·Status: COMPLETED ·Phase: NA
-
Study of Depression, Peptides, and Steroids in Cushing's Syndrome
NCT00004334 ·Status: UNKNOWN
-
Insulin Sensitivity and Substrate Metabolism Before and After Treatment in Patients With Growth Hormone Deficiency
NCT00646815 ·Status: COMPLETED ·Phase: NA
-
Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery
NCT02922257 ·Status: COMPLETED
-
Adrenalectomy Versus Follow-up in Patients With Subclinical Cushings Syndrome
NCT01246739 ·Status: TERMINATED ·Phase: NA
-
Study on the Incidence of Adrenal Insufficiency After Surgery in Primary Aldosteronism Patients Concurrent With or Without Autonomous Cortisol Secretion
NCT06955286 ·Status: RECRUITING
-
The Risk of Adrenal Insufficiency and Cushing Syndrome Associated With Glucocorticoid Therapy in People With Chronic Inflammatory Diseases
NCT03575247 ·Status: COMPLETED
-
Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly
NCT00004332 ·Status: COMPLETED
-
Peripheral Metabolic Effects of Somatostatin
NCT01062529 ·Status: COMPLETED ·Phase: NA
-
Long-term Cardiovascular Risk in Cured Cushing's Patients
NCT00881283 ·Status: TERMINATED
-
Genomic and Metabolomic Markers Reflecting the Complications of Hypercortisolism (CUSHINGOMICS)
NCT04840693 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Long-Term Follow-Up of Survivors of Pediatric Cushing Disease
NCT03831958 ·Status: RECRUITING
-
Ghrelin, Growth Hormone and Cortisol Interaction in Growth Hormone Deficient Patients
NCT00139945 ·Status: COMPLETED ·Phase: NA
-
Glucocorticoid Receptor Antagonism in Subclinical Cushings
NCT00721201 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Low Dose Growth Hormone (GH) on Insulin Sensitivity and Cortisol Production Rates
NCT00517062 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease
NCT00434148 ·Status: COMPLETED ·Phase: PHASE3
-
Extension Study to Assess the Safety and Efficacy of Pasireotide in Participants With Cushing's Disease
NCT00171951 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
NCT00422201 ·Status: TERMINATED ·Phase: PHASE2
-
Preoperative Bexarotene Treatment for Cushing's Disease
NCT00845351 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
NCT05804669 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
The Effect of Pharmacological Antilipolysis on the Metabolic Effects of Ghrelin
NCT01209416 ·Status: COMPLETED ·Phase: NA